https://www.zonebourse.com/cours/action/REGULUS-THERAPEUTICS-INC-46475580/actualite/Regulus-Therapeutics-annonce-le-dosage-du-premier-patient-de-la-troisieme-cohorte-de-l-essai-cliniq-45225152/?utm_source=telegram&utm_medium=social&utm_campaign=share